Find your path to Johan
395 people in our graph share verified history with Johan — schools, employers, funds. One of them is your warm intro.
About
Johan Lund is a physician and former professor with a PhD from Karolinska Institutet and over 25 years of experience in drug development across academia and industry. He has held senior research leadership roles at AstraZeneca, Pfizer, and Celgene, focusing on inflammation, immunology, and CNS, including serving as Chief Scientific Officer for Inflammation & Immunology at Pfizer. As Venture Partner at Sciety, he supports the evaluation of investment opportunities and helps portfolio companies translate scientific research to market.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Experience
- Mesenkia Therapeutics ABCo-founder and Chairman of the Boardcurrent2025 — presentUppsala, Uppsala County, Sweden
- Mesenkia Therapeutics ABInterim Chief Executive Officer and co-founder2023 — 2025Uppsala, Uppsala County, Sweden
- AQILION ABChief Scientific Officercurrent2021 — present
- AQILION ABChairman Of The Board2018 — 2022Helsingborg, Sweden
- NEOGAP Therapeutics ABChairman of the Board of Directorscurrent2019 — present
- Pelago Bioscience ABMember Board Of Directorscurrent2021 — present
- ScietyVenture Partnercurrent2025 — present
- PharmNovoChairman of the Boardcurrent2025 — present
- MBS PharmaFoundercurrent2018 — presentBjärred, Sweden
- NeuVentis Therapeutics ABCEO and Co-Foundercurrent2018 — presentStockholm, Sweden
- Olink ProteomicsBoard member2017 — 2024Uppsala, Sweden
- LIDDSMember Board Of Directors2022 — 2024
- Genagon TherapeuticsMember Board Of Directors2019 — 2024
- Celgene PharmaVice President2016 — 2017Cambridge, MA
- EIT Health Scandinavian CLCBoard Member2015 — 2016Greater Stockholm Metropolitan Area
- Karolinska InstitutetSenior Specialist & Program Lead EIT Health2015 — 2016Greater Stockholm Metropolitan Area
- J. Lund & Associates, LLCManaging Partner2015 — 2016Brookline, MA
- PfizerSenior Vice President & Chief Scientific Officer, Immunoscience Research Unit2012 — 2015Cambridge, MA, USA
- AstraZenecaVice President2008 — 2012
- AstraZenecaVice President2007 — 2008
- AstraZenecaVice president2005 — 2007
- AstraZenecaDirector2003 — 2005
- AstraZenecaDirector2000 — 2003
- AstraZenecaDirector1999 — 2000
- University of BergenProfessor1996 — 1999
- Karolinska InstitutetAssociate Professor1990 — 1996
- UT Southwestern Medical Center at DallasResearch Fellow1987 — 1989
Skills & more
+12 more
Medical AffairsR&DInflammationBiotechnologyBiochemistryTranslational MedicineCROIn VitroINDMedicinal ChemistryClinical TrialsToxicologyFrom Johan's professional profile.
Investments
Board seats
MesenkiaNeogap TherapeuticsOlinkPharmNovo
Per the firm's website.
Colleagues at Sciety
Frequently asked questions
- Who is Johan Lund?
- Johan Lund is a physician and former professor with a PhD from Karolinska Institutet and over 25 years of experience in drug development across academia and industry. He has held senior research leadership roles at AstraZeneca, Pfizer, and Celgene, focusing on inflammation, immunology, and CNS, including serving as Chief Scientific Officer for Inflammation & Immunology at Pfizer. As Venture Partner at Sciety, he supports the evaluation of investment opportunities and helps portfolio companies translate scientific research to market.
- Where does Johan Lund work?
- Johan Lund is Venture Partner at Sciety.
- What does Johan Lund invest in?
- Johan Lund invests in Biotech, Healthtech.
- What boards does Johan Lund sit on?
- Johan Lund holds tracked board seats at Mesenkia, Neogap Therapeutics, Olink, PharmNovo.
- Where did Johan Lund go to school?
- Johan Lund studied at Karolinska Institutet (MD/PhD).
Same school
Also attended Karolinska Institutet40
+ 34 more
Shared employers
Also worked at Mesenkia Therapeutics AB1
Also worked at Olink Proteomics4
Also worked at Pfizer402
+ 396 more
Also worked at AstraZeneca159
+ 153 more










































